Guadalupe Hayes-Mota is a biotechnology, AI, and healthcare executive known for building global systems that deliver life-saving medicines at scale. Across senior leadership roles at Biogen, Amgen, GSK, and Ultragenyx, he led complex manufacturing and supply networks supporting billions of treatments worldwide in rare disease, oncology, and specialty medicine.
He founded and served as CEO of Healr Solutions, an AI-driven company optimizing drug production and distribution across 43 countries before a successful acquisition. Earlier, he contributed to implementation of the Affordable Care Act at the RAND Corporation and directed one of the largest free healthcare systems at UCLA Health.
Guadalupe is Director of the Bioethics Program at Santa Clara University Markkula Center for Applied Ethics. He was appointed by the U.S. HHS Secretary to the NIH Cures Acceleration Network Review Board and advises the European Commission on AI. He writes for Forbes, Fast Company, and STAT.
He was named by Business Insider as one of six powerful LGBTQ+ executives and by PharmaVoice as one of the 100 Most Influential People in the industry.